04:41 PM EDT, 05/20/2024 (MT Newswires) -- Nurix Therapeutics ( NRIX ) said late Monday that David Lacey has stepped down as board chair following the conclusion of its annual stockholders' meeting.

Lacey will remain on the board and will continue to chair the compensation committee and serve as a member of its development advisory committee, the company said.

Nurix said the board has elected board member Julia Gregory as its new board chair.

Price: 16.05, Change: -0.14, Percent Change: -0.86